Premier News
Our recent announcements and latest news
Quality
Quality Assurance VP Speaking at Life Sciences Webcast July 20
DURHAM, N.C., June 29, 2017 — Premier Research’s head of quality assurance will speak on life sciences supplier certification during a webcast hosted by The Knowledge Group. The event takes place Thursday, July 20, from 3 p.m. to 5 p.m. Eastern. The Life Sciences’ Supplier and Contractor Qualification and Control Framework Explored will address challenges...
Data Management & Biostatistics
Coding Expert Joins B3/C3 Format Discussion at WHODrug Meeting
DURHAM, N.C., June 23, 2017 — A Premier Research medical coding expert will take part in a panel discussion on the new WHODrug B3 and C3 formats. Lubomir Tarabcak, Manager of Medical Coding, will be taking part in the hour-long panel at the WHODrug User Group Meeting, June 23 in Chicago. The discussion, to begin...
Data Management & Biostatistics
Quality Expert to Discuss Data Integrity at DIA Annual Meeting
DURHAM, N.C., June 19, 2017 — Data integrity has been a prime focus of pharmaceutical regulators for two decades now, but the focus is sharpening markedly with issuance of new guidance from multiple regulatory authorities. Sherri Hubby, who leads quality assurance, risk, and compliance at Premier Research, will address this trend and its implications at...
Consulting
Risk-Based Decisions Topic of Panel Talk at Quality Consortium
DURHAM, N.C., June 7, 2017 — Premier Research’s leading quality expert will host a panel discussion on risk-based decision-making at the Avoca Quality Consortium’s 2017 summit in Dublin. The discussion, starting at 2:15 p.m. June 8, will address needs in transforming human capital management and improving risk mitigation in clinical trial execution. It’s an ideal...
Consulting
Webinar Explores Expanding Role of Immuno-Oncology Drugs
DURHAM, N.C., MAY 23, 2017 — Interleukin-2, interferon, and other immune-modulating agents have long been used to treat some solid malignancies, but their efficacy is generally limited to immunogenic cancers such as melanoma and kidney cancer. Until now. Today, multiple immuno-oncology pathways are under development, and we’ll explore this promising trend in a webinar on...
Consulting
Experts to Discuss Pediatric Medicines, Wearables at EuroMeeting 2017
DURHAM, N.C., March 27, 2017 — Two Premier Research drug development experts will speak at the Drug Information Association’s EuroMeeting 2017, March 29-31 in Glasgow: Dr. Thomas Laage, Senior Medical Director, will take part in a session on optimizing development of pediatric medicines on Thursday, March 30, from 11 a.m. to 12:30 p.m. Dr. Laage...